Minerva Neurosciences, Inc.
NERV
$2.39
-$0.045-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.26M | -3.75M | -4.27M | 22.51M | -8.23M |
| Total Depreciation and Amortization | 1.40K | 1.40K | 1.40K | 1.40K | 1.40K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 4.30K | 6.40K |
| Total Other Non-Cash Items | 298.20K | 297.20K | 249.70K | -26.27M | 2.64M |
| Change in Net Operating Assets | 916.90K | -617.60K | -1.15M | -599.70K | 1.65M |
| Cash from Operations | -2.04M | -4.07M | -5.17M | -4.35M | -3.94M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.04M | -4.07M | -5.17M | -4.35M | -3.94M |